DO NOT COME HERE!!

Quote

Anonymous

Guest
Dont take this job if you already have a job that is at least ok. The company is starting to panic because sales are flat and now everything is becoming micromanaged to the smallest thing. Trust me, unless you are unemployed stay where you are because we have hit the iceberg and going down fast!! Most of the reps on our team are looking for other opportunities so you have been warned.
 






Anonymous said:
Dont take this job if you already have a job that is at least ok. The company is starting to panic because sales are flat and now everything is becoming micromanaged to the smallest thing. Trust me, unless you are unemployed stay where you are because we have hit the iceberg and going down fast!! Most of the reps on our team are looking for other opportunities so you have been warned.
Click to expand...

Gee,what a surprise!
 






Anonymous said:
Gee,what a surprise!
Click to expand...

It is a surprise to me because this is a good product but once again the company missed the price point. Every product in the class is generic and lunesta has a zero co-pay card and Somaxon wonders why patients dont want to pay 40-50 co-pays and a cash price of 4.00 a pill is just ridiculous.
 






Anonymous said:
Dont take this job if you already have a job that is at least ok. The company is starting to panic because sales are flat and now everything is becoming micromanaged to the smallest thing. Trust me, unless you are unemployed stay where you are because we have hit the iceberg and going down fast!! Most of the reps on our team are looking for other opportunities so you have been warned.
Click to expand...

using anonymous userid it's too easy to post anything here...
some says that benefits are great, someone says sales are growing, other has the co pay problem...other suggest to avoid Somaxon...

what should be the truth ?
 












You guys suck cause you hired mostly tekada losers who conld not sell rozerum! no surprise your sales suck. however, compared to rozerum they are actually similar! great hires!1
 






Anonymous said:
You guys suck cause you hired mostly tekada losers who conld not sell rozerum! no surprise your sales suck. however, compared to rozerum they are actually similar! great hires!1
Click to expand...

For one of the few times on cafe pharma I agree with another post. This company went out and hired all of the dead weight that tekada did not want and now Somaxon is wondering why Silenor sales suck. 99% of the managers are from Tekada and they are doing the same crap with the expansion, bringing over more tekada losers.
 






Anonymous said:
For one of the few times on cafe pharma I agree with another post. This company went out and hired all of the dead weight that tekada did not want and now Somaxon is wondering why Silenor sales suck. 99% of the managers are from Tekada and they are doing the same crap with the expansion, bringing over more tekada losers.
Click to expand...

The reps selling it are not the loosers,its the product that's the looser! Asked Managed Care
who won't give you coverage,even if a doc would write for it over generics!Get real!
 






Anonymous said:
The reps selling it are not the loosers,its the product that's the looser! Asked Managed Care
who won't give you coverage,even if a doc would write for it over generics!Get real!
Click to expand...

You are actually wrong about product not being a good treatment, once again another company trying to say they are different but launching a product in the same old pharma mold that is broken. Somaxon should have price this product dirt cheap and gone after volume like Walmart does. Selling a million of something at 50.00 dollars profit is better than selling a few thousand at 150.00 profit. Do the math!! Making 150 on 100,000 scripts is 15 million vs selling a million scripts at a 50 profit equals 50 million. Hmmm, I will take the 50 mill and build off of that.
 


















Anonymous said:
Thanks for your valuable input TAKEDA reject!!! TAKEDA people are f....king this company up just like you did with your previous one spelled TAKEDA. I got both the spelling and the sorry rep right this time!!!!!!!!!!
Click to expand...

Post #8 is right on target! By the way,Rozerem was actually doing well and gaining MS until Ambien went generic,which is why Silenor will NEVER get off the ground!Every branded product has suffered MS loss since then,and you think your little "piss-ant" company has the product to grow when the others haven't? Get real!
 












Anonymous said:
It is a surprise to me because this is a good product but once again the company missed the price point. Every product in the class is generic and lunesta has a zero co-pay card and Somaxon wonders why patients dont want to pay 40-50 co-pays and a cash price of 4.00 a pill is just ridiculous.
Click to expand...

Good product? Are you kidding me? Look I know people need a job and if this is a way of supporting yourself or a family then more power to you, but get real. Somaxon took a generic drug for a different indication that has been around for a long while and expects physicians to sock their patients with a $40 - $75 co-pay for benefit they could get from the generic? When you consider this cost and the ho-hum efficacy profile it appears that safety is the only reason some patients might choose Silenor - and ask Takeda about how ROZEREM did on that one.

Point is Somaxon is taking advantage of FDA rules that allow them to rape patients who often have no idea that their medication is the EXACT same molecule as a generic but at a different dose. Keep selling if you must because of the pay, but don't kid anyone - this product is a complete branded loser.
 






Anonymous said:
Good product? Are you kidding me? Look I know people need a job and if this is a way of supporting yourself or a family then more power to you, but get real. Somaxon took a generic drug for a different indication that has been around for a long while and expects physicians to sock their patients with a $40 - $75 co-pay for benefit they could get from the generic? When you consider this cost and the ho-hum efficacy profile it appears that safety is the only reason some patients might choose Silenor - and ask Takeda about how ROZEREM did on that one.

Point is Somaxon is taking advantage of FDA rules that allow them to rape patients who often have no idea that their medication is the EXACT same molecule as a generic but at a different dose. Keep selling if you must because of the pay, but don't kid anyone - this product is a complete branded loser.
Click to expand...

For those of us that know the sleep market and have sold in it,this post tells it like it is!P&G waiting in the wings to take it OTC very soon!
 






Anonymous said:
For those of us that know the sleep market and have sold in it,this post tells it like it is!P&G waiting in the wings to take it OTC very soon!
Click to expand...

P&G can take this OTC but Somaxon owns the patent dumb ass and the patent will be protected until 2019 when the case goes to court. Do some research before opening your pie hole.
 


















Anonymous said:
Once again those of us that do our homework before speaking through our pie hole are vindicated. Patent case won!!!
Click to expand...

mmmm You better do Your homework again...

no patent case won, pateng litigation against Mylan, Par & Actavis are ongoing and it will probably take months before somaxon receives any news.

maybe you're referring to a new patent to be issued in next months covering the "food effect" in the patent group "method of use" of doxepin...
they're just securing new patents to slow down generic anda filer, but no case won at the moment
 












Top Bottom
Back
Quote